BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15469848)

  • 1. Assembling a gene regulatory network for specification of the B cell fate.
    Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
    Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
    Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic networks that regulate B lymphopoiesis.
    Medina KL; Singh H
    Curr Opin Hematol; 2005 May; 12(3):203-9. PubMed ID: 15867576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic regulation of bone development.
    Horowitz MC; Lorenzo JA
    Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contingent gene regulatory networks and B cell fate specification.
    Singh H; Medina KL; Pongubala JM
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):4949-53. PubMed ID: 15788530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
    Linderson Y; French NS; Neurath MF; Pettersson S
    Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.
    Sigvardsson M; Clark DR; Fitzsimmons D; Doyle M; Akerblad P; Breslin T; Bilke S; Li R; Yeamans C; Zhang G; Hagman J
    Mol Cell Biol; 2002 Dec; 22(24):8539-51. PubMed ID: 12446773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.
    Dias S; Silva H; Cumano A; Vieira P
    J Exp Med; 2005 Mar; 201(6):971-9. PubMed ID: 15767371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
    Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
    Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early B cell factor: Regulator of B lineage specification and commitment.
    Lukin K; Fields S; Hartley J; Hagman J
    Semin Immunol; 2008 Aug; 20(4):221-7. PubMed ID: 18722139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
    Kee BL; Murre C
    J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
    DeKoter RP; Singh H
    Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors.
    Rolink AG; Nutt SL; Melchers F; Busslinger M
    Nature; 1999 Oct; 401(6753):603-6. PubMed ID: 10524629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of EBF and Pax-5 in B lineage commitment and development.
    Maier H; Hagman J
    Semin Immunol; 2002 Dec; 14(6):415-22. PubMed ID: 12457614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age.
    Lescale C; Dias S; Maƫs J; Cumano A; Szabo P; Charron D; Weksler ME; Dosquet C; Vieira P; Goodhardt M
    Aging Cell; 2010 Jun; 9(3):410-9. PubMed ID: 20331442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.